Cite
APA Citation
Weinstock-Guttman, B., Bermel, R., Cutter, G., Freedman, M. S., Leist, T. P., Ma, X., Kile, D., Musch, B., Reder, A. T., & Wolinsky, J. S. (2022). ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial. Multiple sclerosis, 28, 790–800. http://access.bl.uk/ark:/81055/vdc_100147158190.0x000021